Low gamma‐butyrobetaine dioxygenase (BBOX1) expression as a prognostic biomarker in patients with clear cell renal cell carcinoma: a machine learning approach

Gamma‐butyrobetaine dioxygenase (BBOX1) is a catalyst for the conversion of gamma‐butyrobetaine to l‐carnitine, which is detected in normal renal tubules. The purpose of this study was to analyze the prognosis, immune response, and genetic alterations associated with low BBOX1 expression in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Kyu‐Shik, Moon, Kyoung Min, Min, Kyueng‐Whan, Jung, Woon Yong, Shin, Su‐Jin, Lee, Seung Wook, Kwon, Mi Jung, Kim, Dong‐Hoon, Oh, Sukjoong, Noh, Yung‐Kyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073934/
https://www.ncbi.nlm.nih.gov/pubmed/36864013
http://dx.doi.org/10.1002/cjp2.315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073934/
https://www.ncbi.nlm.nih.gov/pubmed/36864013
http://dx.doi.org/10.1002/cjp2.315

Ejemplares similares